<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02767258</url>
  </required_header>
  <id_info>
    <org_study_id>EE/UFMG</org_study_id>
    <nct_id>NCT02767258</nct_id>
  </id_info>
  <brief_title>Effect of Nursing Care on Prevention of Dry Eye</brief_title>
  <official_title>Randomized Clinical Trial: Effect of Nursing Interventions on Prevention of Dry Eye in Critically Ill Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Diego Dias de Araújo</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>State University of Montes Claros</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Conselho Nacional de Desenvolvimento Científico e Tecnológico</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Federal University of Minas Gerais</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Clinical trial for prevention, randomized controlled, parallel, double-blind, with three
      arms, which purpose is verify the nursing interventions (artificial tear gel and liquid
      artificial tears)effects to prevent dry eye in adult patients admitted in ICU.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Critically ill patients are at higher risk for dry eye and the mechanisms responsible for
      ocular lubrication and protection can be compromised. However, the literature diverges on
      which is the best clinical practice for treatment. Thus, the general objective of this study
      was to evaluate the risk for developing dry eye in critically ill patients and the
      effectiveness of three types of interventions: eye gel and eyedrops (control group). The
      specific objectives were: verify the most effective intervention for the prevention of dry
      eye from the available literature and provided by: eye gel compared to the control group
      eyedrops who received eye care through randomized controlled clinical trial. Patients and
      methods: This study is a randomized controlled trial to determine the best care for the
      prevention of dry eye from those available on the market (eye drops and eye gel), in the
      period from 14/01/2016 to 31/12/2019 . The expected result is: negative values in Schirmer
      test and no corneal ulcers presence.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 1, 2016</start_date>
  <completion_date type="Anticipated">December 31, 2019</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Dry Eye</measure>
    <time_frame>Five consecutive days</time_frame>
    <description>Interventions will be applied in both eyes of the patients from 12 to 12 hours for five consecutive days. Schirmer test will be applyed to evaluate the lacrimal volume. Fluorescein test will be applyed to evaluate the ocular surface.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Dry Eye Syndromes</condition>
  <arm_group>
    <arm_group_label>Sham Comparator: Eye drop</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Eye drop LACRIBELL® - two drops each eye, two times a day, after eye cleansing.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>VIDISIC® GEL</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Ocular gel VIDISIC® GEL applied two times a day at the lower palpebra from medium line to the lateral border.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>LACRIBELL®</intervention_name>
    <description>Hypromellose and dextran based eyedrop, used in the treatment of dry eye.</description>
    <arm_group_label>Sham Comparator: Eye drop</arm_group_label>
    <other_name>liquid artificial tears</other_name>
    <other_name>eyedrop</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>VIDISIC® GEL</intervention_name>
    <description>Carbomer based gel, used in the treatment of dry eye.</description>
    <arm_group_label>VIDISIC® GEL</arm_group_label>
    <other_name>artificial tear gel</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Be over 18 years;

          -  Did not present dry eye at the time of admission;

          -  Stay in the ICU for at least 24 hours;

          -  Be in mechanical ventilation therapy;

          -  Glance less than 5 per minute;

          -  Comatose, sedated or Glasgow less than or equal to 7;

          -  Consent to participate in research or have.

        Exclusion Criteria:

          -  Have not the responsabille authorization;

          -  Patients with severe eye disease or with history of adverse effects after use of any
             of the interventions proposed and not tolerate the treatment: artificial tear gel,
             artificial tear liquid and saline 0.9%.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>100 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Diego D Araújo, PhD student</last_name>
    <role>Principal Investigator</role>
    <affiliation>State University of Montes Claros, Minas Gerais, Brazil</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Diego D Araújo, PhD student</last_name>
    <phone>55 (38) 3213 2150</phone>
    <phone_ext>Brazil</phone_ext>
    <email>diego.dias1508@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Tânia CM Chianca, PhD</last_name>
    <phone>55 (31) 3409 9887</phone>
    <phone_ext>Brazil</phone_ext>
    <email>taniachianca@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Santa de Misericórdia Montes Claros</name>
      <address>
        <city>Montes Claros</city>
        <state>Minas Gerais</state>
        <zip>39402-218</zip>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Diego Dias de Araújo</last_name>
      <phone>(38)3213-2150</phone>
      <email>diego.dias1508@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Diego Dias de Araújo</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <reference>
    <citation>de Araújo DD, Almeida NG, Silva PM, Ribeiro NS, Werli-Alvarenga A, Chianca TC. Prediction of risk and incidence of dry eye in critical patients. Rev Lat Am Enfermagem. 2016;24:e2689. doi: 10.1590/1518-8345.0897.2689. Epub 2016 May 17. English, Portuguese, Spanish.</citation>
    <PMID>27192415</PMID>
  </reference>
  <verification_date>February 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 6, 2016</study_first_submitted>
  <study_first_submitted_qc>May 9, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 10, 2016</study_first_posted>
  <last_update_submitted>February 13, 2017</last_update_submitted>
  <last_update_submitted_qc>February 13, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">February 14, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Federal University of Minas Gerais</investigator_affiliation>
    <investigator_full_name>Diego Dias de Araújo</investigator_full_name>
    <investigator_title>Teacher and Student Doctoral Nursing</investigator_title>
  </responsible_party>
  <keyword>Dry eye</keyword>
  <keyword>Diseases of the eye and adnexa</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Keratoconjunctivitis Sicca</mesh_term>
    <mesh_term>Dry Eye Syndromes</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lubricant Eye Drops</mesh_term>
    <mesh_term>Ophthalmic Solutions</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>The study and the information provided will be confidential and used only for purposes of this research. Disclosure of information will be anonymous and in conjunction with the responses of a group of people, never individually.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

